Clinical Trial Update: Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vaginal misoprostol for cervical ripening prior to endometrial biopsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: University of Saskatchewan | Conditions: Menorrhagia, Endometrial Biopsy | Phase 3 | Status: WITHDRAWN